294 related articles for article (PubMed ID: 22027126)
1. Determination of Vasopressin and Desmopressin in urine by means of liquid chromatography coupled to quadrupole time-of-flight mass spectrometry for doping control purposes.
Thomas A; Solymos E; Schänzer W; Baume N; Saugy M; Dellanna F; Thevis M
Anal Chim Acta; 2011 Nov; 707(1-2):107-13. PubMed ID: 22027126
[TBL] [Abstract][Full Text] [Related]
2. Doping control analysis of desmopressin in human urine by LC-ESI-MS/MS after urine delipidation.
Esposito S; Deventer K; T'Sjoen G; Vantilborgh A; Van Eenoo P
Biomed Chromatogr; 2013 Feb; 27(2):240-5. PubMed ID: 22740500
[TBL] [Abstract][Full Text] [Related]
3. Mass spectrometric determination of gonadotrophin-releasing hormone (GnRH) in human urine for doping control purposes by means of LC-ESI-MS/MS.
Thomas A; Geyer H; Kamber M; Schänzer W; Thevis M
J Mass Spectrom; 2008 Jul; 43(7):908-15. PubMed ID: 18563864
[TBL] [Abstract][Full Text] [Related]
4. Determination of IGF-1 and IGF-2, their degradation products and synthetic analogues in urine by LC-MS/MS.
Thomas A; Kohler M; Schänzer W; Delahaut P; Thevis M
Analyst; 2011 Mar; 136(5):1003-12. PubMed ID: 21157622
[TBL] [Abstract][Full Text] [Related]
5. Determination of prohibited, small peptides in urine for sports drug testing by means of nano-liquid chromatography/benchtop quadrupole orbitrap tandem-mass spectrometry.
Thomas A; Walpurgis K; Krug O; Schänzer W; Thevis M
J Chromatogr A; 2012 Oct; 1259():251-7. PubMed ID: 22901302
[TBL] [Abstract][Full Text] [Related]
6. Qualitative detection of desmopressin in plasma by liquid chromatography-tandem mass spectrometry.
Esposito S; Deventer K; T'Sjoen G; Vantilborgh A; Delbeke FT; Goessaert AS; Everaert K; Van Eenoo P
Anal Bioanal Chem; 2012 Mar; 402(9):2789-96. PubMed ID: 22318696
[TBL] [Abstract][Full Text] [Related]
7. Determination of Synacthen in urine for sports drug testing by means of nano-ultra-performance liquid chromatography/tandem mass spectrometry.
Thomas A; Kohler M; Schänzer W; Kamber M; Delahaut P; Thevis M
Rapid Commun Mass Spectrom; 2009 Sep; 23(17):2669-74. PubMed ID: 19630025
[TBL] [Abstract][Full Text] [Related]
8. A general screening method for doping agents in human urine by solid phase extraction and liquid chromatography/time-of-flight mass spectrometry.
Kolmonen M; Leinonen A; Pelander A; Ojanperä I
Anal Chim Acta; 2007 Feb; 585(1):94-102. PubMed ID: 17386652
[TBL] [Abstract][Full Text] [Related]
9. Preventive doping control screening analysis of prohibited substances in human urine using rapid-resolution liquid chromatography/high-resolution time-of-flight mass spectrometry.
Vonaparti A; Lyris E; Angelis YS; Panderi I; Koupparis M; Tsantili-Kakoulidou A; Peters RJ; Nielen MW; Georgakopoulos C
Rapid Commun Mass Spectrom; 2010 Jun; 24(11):1595-609. PubMed ID: 20486255
[TBL] [Abstract][Full Text] [Related]
10. Fast analysis of doping agents in urine by ultra-high-pressure liquid chromatography-quadrupole time-of-flight mass spectrometry. II: Confirmatory analysis.
Badoud F; Grata E; Perrenoud L; Saugy M; Rudaz S; Veuthey JL
J Chromatogr A; 2010 Jun; 1217(25):4109-19. PubMed ID: 19939397
[TBL] [Abstract][Full Text] [Related]
11. Simple and accurate quantitative analysis of seven prohibited threshold substances in human urine by liquid chromatography/tandem mass spectrometry in doping control.
Lee KM; Kim HJ; Jeong ES; Yoo HH; Kwon OS; Jin C; Kim DH; Lee J
Rapid Commun Mass Spectrom; 2011 Aug; 25(16):2261-7. PubMed ID: 21755547
[TBL] [Abstract][Full Text] [Related]
12. Mass spectrometric characterization of a prolyl hydroxylase inhibitor GSK1278863, its bishydroxylated metabolite, and its implementation into routine doping controls.
Thevis M; Milosovich S; Licea-Perez H; Knecht D; Cavalier T; Schänzer W
Drug Test Anal; 2016 Aug; 8(8):858-63. PubMed ID: 26361079
[TBL] [Abstract][Full Text] [Related]
13. Doping control analysis for adrafinil and its major metabolites in human urine.
Lu J; Wang X; Yang S; Liu X; Qin Y; Shen L; Wu Y; Xu Y; Wu M; Ouyang G
Rapid Commun Mass Spectrom; 2009 Jun; 23(11):1592-600. PubMed ID: 19399790
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous analysis of fourteen tertiary amine stimulants in human urine for doping control purposes by liquid chromatography-tandem mass spectrometry and gas chromatography-mass spectrometry.
Lu J; Wang S; Dong Y; Wang X; Yang S; Zhang J; Deng J; Qin Y; Xu Y; Wu M; Ouyang G
Anal Chim Acta; 2010 Jan; 657(1):45-52. PubMed ID: 19951756
[TBL] [Abstract][Full Text] [Related]
15. LC-MS/TOF and UHPLC-MS/MS study of in vivo fate of rifamycin isonicotinyl hydrazone formed on oral co-administration of rifampicin and isoniazid.
Prasad B; Singh S
J Pharm Biomed Anal; 2010 Jul; 52(3):377-83. PubMed ID: 19692195
[TBL] [Abstract][Full Text] [Related]
16. Regulatory control of glycopyrrolate in performance horses using validated UHPLC/MS-MS methods.
Rumpler MJ; Sams RA; Colahan P
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Mar; 889-890():130-7. PubMed ID: 22377405
[TBL] [Abstract][Full Text] [Related]
17. Rapid screening of anabolic steroids in horse urine with ultra-high-performance liquid chromatography/tandem mass spectrometry after chemical derivatisation.
Wong CH; Leung DK; Tang FP; Wong JK; Yu NH; Wan TS
J Chromatogr A; 2012 Apr; 1232():257-65. PubMed ID: 22265177
[TBL] [Abstract][Full Text] [Related]
18. Doping control analysis of trenbolone and related compounds using liquid chromatography-tandem mass spectrometry.
Thevis M; Guddat S; Schänzer W
Steroids; 2009 Mar; 74(3):315-21. PubMed ID: 19007801
[TBL] [Abstract][Full Text] [Related]
19. Mass spectrometric identification and characterization of new clomiphene metabolites in human urine by liquid chromatography-quadrupole time-of-flight tandem mass spectrometry.
Lu J; He G; Wang X; Xu Y; Wu Y; Dong Y; He Z; Liu X; Bo T; Ouyang G
J Chromatogr A; 2012 Jun; 1243():23-32. PubMed ID: 22579489
[TBL] [Abstract][Full Text] [Related]
20. Urine analysis concerning xenon for doping control purposes.
Thevis M; Piper T; Geyer H; Schaefer MS; Schneemann J; Kienbaum P; Schänzer W
Rapid Commun Mass Spectrom; 2015 Jan; 29(1):61-6. PubMed ID: 25462364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
